palmitate, which is insufficient time for the suppressed glucose-induced insulin secretion [6] . Thus, the only functional change in our system was a left-shifted glucose concentration -insulin secretion curve.
Materials and methods
Islet isolation and culture. Islets were isolated from 200 g male Sprague-Dawley rats (Taconic, Germantown, N. Y., USA) using an adaptation of the method of Gotoh et al. [16] : pancreatic duct infiltration with collagenase (Serva, Heidelberg, Germany), Histopaque gradient separation (Sigma, St. Louis, Mo., USA), and hand picking. They were cultured overnight in RPMI 1640 medium containing 5.5 mmol/l glucose, 2 mmol/l glutamine, 10 % newborn calf serum, 100 units/ml penicillin, and 0.1 mg/ml streptomycin (all from Gibco, Grand Island, N. Y., USA), followed by an additional 24 h of culture with 0.25 mmol/l palmitate (sodium salt) in 2 % ethanol or 2 % ethanol alone. The insulin secretion study incorporated Triacsin C in the culture protocol which is an inhibitor of long chain acyl-CoA synthetase (Biomol, Plymouth Meeting, Pa., USA) [17] [18] [19] . Thus, four groups of additives were used during the 24-h culture: 0.25 mmol/l palmitate in 2 % ethanol plus 0.05 m g/ml Triacsin C in 0.5 % dimethyl sulphoxide (DMSO); 0.25 % palmitate in 2 % ethanol plus 0.5 % DMSO; 2 % ethanol plus 0.05 m g/ml Triacsin C in 0.5 % DMSO; 2 % ethanol plus 0.5 % DMSO. Post-culture, all experiments were preceded by a 30-min preincubation at 2.8 mmol/l glucose with no additives.
Insulin secretion. Triplicate batches of 10 islets in glass vials containing 1 ml Kreb's Ringer Buffer (KRB), 10 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES), 0.5 % bovine serum albumin (BSA), glucose (2.8, 8.3, 27.7 mmol/l), were incubated for 60 min in a 37°C shaking water bath. The medium was separated from the islets by gentle centrifugation (500 rev/min 5 min at 10°C) and stored at -20°C pending insulin measurement by radioimmunoassay (RIA) [20] .
Glucose utilization. Islet glucose utilization was measured by the method of Ashcroft et al. [21] . C] glucose (NEN, Cambridge, Mass., USA). The reaction was carried out in a 1-ml cup in a 20 ml scintillation vial capped by a rubber stopper with a centre well that contained filter paper (Kontes, Vineland, N. J., USA). Islet metabolism was stopped and the CO 2 liberated with 300 m l 1 mol/l HCl injected through the stopper into the cup containing the islets. CO 2 was trapped in the filter paper by injecting 100 m l 1 mol/l KOH into the centre well, followed 2 h later by liquid scintillation counting. Tubes containing [ 14 C] NaHCO 3 and no islets were used to estimate the recovery of 14 CO 2 in the filter paper which was routinely close to 100 %.
Glucokinase and hexokinase activity. Glucose phosphorylation was measured in islet extracts using the method of Liang et al. [22] that measures NAD + conversion to NADH by exogenous glucose 6-phosphate dehydrogenase [22] . All chemicals were from Sigma unless otherwise stated. Three hundred islets per individual rat were homogenized at 5°C in 1 m l/islet of buffer (1 mmol/l EDTA, 20 mmol/l K 2 HPO 4 , 110 mmol/l KCl, 5 mmol/l dithiothreitol) by 25 strokes of a machine-driven Teflon pestle in a Kontes glass homogenizer (0.004-0.006 inch). Aliquots (20 m l × 3) were used to measure DNA content [23] . Following a 10-min centrifugation at 12000 g to remove the mitochondrial-bound hexokinase [24] , 5-ml aliquots were added to 100 m l of reaction buffer consisting of 50 mmol/l HEPES/ HCl pH 7.6, 5 mmol/l ATP, 100 mmol/l KCl, 7.4 mmol/l MgCl 2 , 15 mmol/l b -mercaptoethanol, 0.5 mmol/l NAD + , 0.05 % BSA, glucose (0.03, 0.06, 0.125, 0.25, 0.5, 6, 12, 24, 60, 100 mmol/l), and 0.7 unit/ml glucose 6-phosphate dehydrogenase from Leuconostoc mesenteroides (Boerhinger Mannheim, Indianapolis, Ind., USA). After 90 min at 30°C, the reaction was stopped with 1 ml 500 mmol/l NaHCO 3 pH 9.4. Triplicate samples were performed at each glucose concentration in parallel with reagent blanks (no homogenate) and a tissue blank (islet homogenate in reaction buffer that contained 0 mmol/l glucose). The standard curve was glucose 6-phosphate (0.3-3 nmol) in reaction buffer that contained 100 mmol/l glucose. The mean of replicate results for each glucose concentration was obtained to give a single data point. Glucokinase and hexokinase V max and K m were calculated by linear regression from an Eadie-Scatchard plot after extrapolating the data to 37°C assuming a Q 10 of 2 [25] , followed by 10 cycles of the method of Spears et al. [26] to separate hexokinase and glucokinase activity.
The method was adapted to measure cytoplasmic and mitochondrial-bound hexokinase activity. Islet homogenization was carried out as described with a portion undergoing the 12000 g centrifugation. Glucose phosphorylation was measured as described using glucose concentrations of 0.03, 0.06, 0.125, 0.25, 0.5 mmol/l in equivalent amounts of the uncentrifuged extract (whole) and the post-centrifugation supernatant (cytoplasm) and pellet (mitochondria/microsomes). Hexokinase V max and K m were calculated by linear regression.
Statistical analysis
All data are expressed as mean ± SEM with the "n" values being the number of experiments performed. Statistical significance was determined by unpaired Student's t-test or one-way analysis of variance (ANOVA).
Results
Insulin secretion. As expected, exposing islets for 24 h to 0.25 mmol/l palmitate caused a "left-shifted" glucose concentration-insulin secretion curve: insulin release was raised at 2.8 and 8.3 mmol/l glucose (p < 0.006 for both) as opposed to no change at 27.7 mmol/l glucose ( Table 1) . Adding Triacsin C (0.05 m g/ml), an inhibitor of long chain acyl-CoA synthetase [17] [18] [19] , to the 24-h culture prevented the glucose hypersensitivity so that the insulin responses at 2.8 and 8.3 mmol/l glucose were no longer raised compared to the control islets. Interpretation of the result at 2.8 mmol/l glucose was complicated since the islets given palmitate and Triacsin C had higher insulin output than the Triacsin C-treated controls (0.20 ± 0.03 vs 0.11 ± 0.01 pmol, p < 0.018). In contrast, the results at 8.3 mmol/l glucose were clear-cut. Triacsin C significantly reduced insulin output in the palmitate-treated islets (0.36 ± 0.04 palmitate + Triacsin C islets vs 0.53 ± 0.05 pmol palmitate islets, p < 0.027) to a value that was not significantly different from either control group. A final observation of note was the effect of Triacsin C to inhibit insulin secretion at 27.7 mmol/l glucose in the control islets (p < 0.024), but not at the lower glucose concentrations.
Glucose utilization and oxidation. To investigate the mechanism of the lowered glucose set-point for insulin secretion, islet glucose utilization (n = 6) and oxidation (n = 5) were measured (Fig. 1) . Both results showed the same pattern as insulin secretion: significantly augmented at 2.8 and 8.3 mmol/l glucose as opposed to no change at 27.7 mmol/l. Note the "stepup" for both measures was fully present at 2.8 mmol/ l glucose as shown by there being no additional increase in the delta values at the higher glucose concentrations for either measurement. Thus, the causative factor was a regulatory process for basal islet glucose usage rather than being active at physiologic glucose concentrations. Furthermore, the parallel utilization and oxidation patterns with palmitate localized the upregulated site to early glycolysis, up to phosphofructokinase.
Glucose phosphorylation. We next investigated glucokinase and hexokinase activities in the supernatant of islet extracts that had undergone a 12000 g centrifugation (Table 2) . Islet DNA was unaffected by the palmitate. Hexokinase V max was increased in the palmitate-exposed islets (p < 0.047) with no change in K m . In contrast, glucokinase activity was unchanged.
Fractionated hexokinase activity.
A general characteristic of hexokinase is that it exists in two pools, free in the cytoplasm and bound to mitochondria [27] . The previous measurement included only the cytoplasmic fraction. To investigate whether redistribution of the enzyme between the pools accounted for the raised cytoplasmic activity with palmitate, hexokinase kinetics were measured in whole islet extracts and in the post-centrifugation cytoplasm (supernatant) and mitochondrial (pellet) fractions (Fig. 2) . Hexokinase V max was increased by 25 % in whole extracts of palmitate-exposed islets (p < 0.013). The cytoplasm and mitochondrial fractions showed similar increases although only the former value was significant; K m values were unchanged in all groups.
Discussion
In this study, the heightened glucose sensitivity for insulin secretion with long-term exposure of islets to fatty acids was investigated. The important findings were: comparably increased islet glucose utilization and oxidation, with the step-up being fully manifest at 2.8 mmol/l glucose; increased activity (V max ) of hexokinase in islet extracts as opposed to no change in glucokinase; Triacsin C averted the beta-cell glucose hypersensitivity. Based on these data we propose that an upregulated activity of hexokinase causes the beta-cell glucose hypersensitivity, and a raised cellular level of long chain acyl-CoA esters is an essential factor. A similar conclusion regarding the causative role of hexokinase was recently reported in abstract form based on the use of oleate in transformed beta-cells [28] . Possible mechanisms based on known modulatory effects of fatty acids include acylation [29] , increased gene transcription [30] , increased production of long chain-CoA products, or a direct effect of fatty acid metabolites on the enzyme activity. Regarding the latter, an inhibitory effect of long chain acyl-CoA esters has been reported for glucokinase [31, 32] , phosphofructokinase [33] , and glucose 6-phosphatase [34] : we are not aware of any reports of stimulation of a glycolytic enzyme such as that noted in this study. No attempt to address these different possibilities was made in this study. The term hexokinase is used to represent a family of three low K m isoforms with different tissue distribution and regulation [27] . The beta-cell isoform(s) has not been delineated. Insight into this issue is needed before investigating the basis for the increased hexokinase activity with fatty acids. When considering our results, an important issue is the normal beta-cell sensor for glucose metabolism and insulin secretion is glucokinase, the high K m glucose phosphorylation enzyme [35, 36] . Hexokinase is present in beta-cells in amounts comparable to glucokinase [37] , but it normally has a minimal regulatory role over glucose metabolism because of insensitivity to physiological levels of glucose and endproduct inhibition by glucose 6-phosphate [38, 39] . As such, a shift in the glucose set-point for insulin secretion would be predicted to reflect a variation in glucokinase activity. The possibility that glucokinase was inhibited by long chain acyl-CoA esters thereby lowering glucose 6-phosphate levels and deinhibiting hexokinase was excluded in the palmitate-treated islets by the lack of change in glucokinase activity on direct measurement, and the fact that upregulation of glucose metabolism was fully evident at 2.8 mmol/ l glucose (glucokinase K m ≈ 15 mmol/l glucose). Instead, the latter finding is more compatible with the postulated hexokinase regulatory effect in keeping with the observed increase in its activity.
A noteworthy finding was the dichotomy between the islet functional parameters at 2.8 mmol/l glucose (insulin secretion 190 % of control, glucose usage 170 %, and glucose oxidation 210 %) and the considerably smaller increase (25-35 %) in hexokinase activity measured in islet extracts. This result suggests a complex process in the intact beta-cell. Islets of diabetic rats are known to have increased glucose 6-phosphatase activity [40, 41] . One possibility is that fatty acids induce a similar effect, resulting in lowered glucose 6-phosphate levels and augmented hexokinase activity on that basis. In keeping with that idea, Clore et al. [42] recently suggested a regulatory role for fatty acyl-CoA over glucose 6-phosphatase gene expression in liver. An alternate hypothesis is that elevated long chain acyl-CoAs enhanced exocytosis as suggested previously [5] . The energy use from insulin secretion would activate phosphofructokinase and increase flux through hexokinase because of lowered glucose 6-phosphate levels. Both of these effects depend on the allosteric regulation of hexokinase and thus would not be evident in islet extracts. Our studies do not differentiate among these possibilities; however, they emphasize the potentially important role of hexokinase in regulating glucose entry to the glycolytic pathway with long-term exposure of betacells to fatty acids.
The approach taken to localize the step-up in betacell glucose metabolism was to compare the patterns The data are expressed as mean ± SEM for six experiments. The culture protocol and measurement of glucose phosphorylation were carried out as described in the text for glucose utilization and glucose oxidation in the palmitate-treated islets. Glucose utilization was measured as the conversion of H] glucose to [ 3 H] H 2 O. The labelled water is given off at the triose phosphate isomerase reaction [39] so this technique assessed glycolysis up to the generation of 3 carbon fragments. Glucose oxidation is dependent on all the steps in glucose metabolism through mitochondrial oxidation. Comparing the two curves allowed stepups in glucose metabolism to be localized to before or after the triose phosphate isomerase reaction. Finding identical curves localized the site of upregulation to the former, with the major candidates being GLUT2, glucose phosphorylation by glucokinase or hexokinase, and phosphofructokinase. Finding the step-up in glucose usage was fully present at 2.8 mmol/l glucose eliminated GLUT2 and glucokinase since both are high K m processes with values of 10-15 mmol/l glucose, narrowing the choice to the low K m enzyme, hexokinase, or activation of phosphofructokinase via an alteration in the cellular energy state.
A particularly interesting finding was the effect of Triacsin C to inhibit insulin output to 27.7 mmol/l glucose in the control islets. Substantial data have implicated long chain acyl-CoA esters as second messengers for glucose-induced insulin secretion, with the coupling to glucose metabolism being an inhibitory regulation of malonyl CoA on long chain acyl-CoA ester metabolism by carnitine palmitoyl transferase I [5, 43, 44] . The current finding supports that idea by showing that inhibiting the production of long chain acyl-CoA esters with Triacsin C impaired glucose-induced insulin secretion. At first glance, the effect appears weak (30 % reduction in insulin output at 27.7 mmol/l glucose). However, this study was not designed to test that question, and the experimental protocol probably underestimated the inhibitory effect of Triacsin C since it was administered during the 24-h culture period, but then the insulin secretion study was performed in the absence of Triacsin C after a 30-min preincubation also without Triacsin C. The inference is that Triacsin C may be a potent inhibitor of glucose-induced insulin secretion. Note that the same effect was not present in the palmitate-cultured islets. Whether that result reflects higher long chain acyl-CoA ester cellular levels that are insufficiently inhibited by the Triacsin C rather than another explanation is unknown.
In summary, we speculate that the lowered glucose set-point for insulin secretion with long-term exposure of islets to non-esterified fatty acid (in this case, palmitate) stems from augmented regulation by hexokinase of the flux of glucose metabolism in betacells. Important for this suggestion is the recognition that only a small increase of active hexokinase activity is needed to "left shift" glucose concentration-insulin secretion relationship because of the very low K m of this enzyme. Indeed, our results clearly showed that glucokinase continued to be the dominant regulator of beta-cell glucose sensitivity as shown by the multifold increase in insulin secretion and glucose utilization from 2.8 to 27.7 mmol/l glucose. Therefore, palmitate did not alter the beta-cell "glucose sensing" mechanism per se as reflected in normal glucokinase activity. Instead, the heightened beta-cell glucose sensitivity was secondary to a raised basal level of insulin secretion. 
